DF2726A, a new IL-8 signalling inhibitor, is able to counteract chemotherapy-induced neuropathic pain

Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting side effect of several anti-neoplastics and a main cause of sensory disturbances in cancer survivors, negatively impacting patients’ quality of life. Peripheral nerve degeneration or small fibre neuropathy is generally accep...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandolini, Laura, Castelli, Vanessa, Aramini, Andrea, Giorgio, Cristina, Bianchini, Gianluca, Russo, Roberto, De Caro, Carmen, d’Angelo, Michele, Catanesi, Mariano, Benedetti, Elisabetta, Giordano, Antonio, Cimini, Annamaria, Allegretti, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692352/
https://www.ncbi.nlm.nih.gov/pubmed/31409858
http://dx.doi.org/10.1038/s41598-019-48231-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692352/
https://www.ncbi.nlm.nih.gov/pubmed/31409858
http://dx.doi.org/10.1038/s41598-019-48231-z

Ejemplares similares